October 6, 2005
On Tuesday, President Bush tried to reassure us by saying he will use the military to enforce a quarantine to prevent the spread of an avian influenza pandemic. I would much rather hear from our president that the federal government will give all the necessary economic support to produce as rapidly as possible a vaccine for the H5N1 (avian) influenza virus. This is the only effective way to prevent a pandemic: a mass vaccination as was done against polio. A Centers for Disease Control director recently said that a vaccine against the avian influenza virus is going to be available but there are not sufficient funds to mass-produce it soon enough.
April 29, 1990
On first reading, I thought that "Vaccine to Fight Drug Addiction Is Needed" (March 1) was a Swiftian exercise. But then I realized that satire never appears on the Business pages of The Times. The assumption that desire for euphoria is a disease--that is, an unnatural state--makes for an egregiously false foundation on which to build an argument. For the overwhelming evidence that such a desire (yea, need) is innate rather than abnormal in higher animals, you should read "Intoxication: Life in Pursuit of Artificial Paradise," by Ronald K. Siegel, a Ph.D.
July 25, 2009 |
Hundreds of thousands of Americans could die over the next two years if the vaccine and other control measures for the new H1N1 influenza are not effective, and, at the pandemic's peak, as much as 40% of the workforce could be affected, according to new estimates from the Centers for Disease Control and Prevention. That is admittedly a worst-case scenario that the federal agency says it doesn't expect to occur.
July 23, 2009 |
The federal government and vaccine makers are seeking thousands of volunteers, from babies to the elderly, to test whether a new swine flu vaccine works. The National Institutes of Health tapped a network of medical centers around the country to begin a series of studies on a vaccine for the H1N1 flu pandemic. The first shots will go into the arms of healthy adults, of any age, in early August. If there are no immediate safety concerns, such as allergic reactions, testing would begin in children as young as 6 months.
July 24, 1986 |
The Food and Drug Administration on Wednesday announced its approval of the first human vaccine produced by genetic engineering, which will be used to protect against Hepatitis B. "This vaccine opens up a whole new era of vaccine production," FDA Commissioner Frank E. Young said at a press conference. "These techniques should be able to be extended to any virus or parasite to produce other vaccines that normally cannot be propagated in the laboratory."
August 16, 1985 |
The virus suspected of causing AIDS has so many variations in its genetic structure that developing a vaccine against the disease may be difficult, if it can be done at all, researchers said Thursday. Scientists at the National Cancer Institute said that they looked at samples of the suspect virus found in 18 patients with AIDS or at high risk of getting the disease, and each isolated virus showed a different variation in its genetic structure.
CALIFORNIA | LOCAL
June 19, 1989 |
There has never been an effective vaccine for malaria, scourge of the tropics and killer of millions. Now, many experts--although cautious--agree that rapidly advancing knowledge about immunology and malaria has reached the threshold of producing a vaccine that can prevent one of the most widespread and troublesome diseases ever known. And in the race to discover a preventive agent, one researcher, Dr. Manuel E. Patarroyo, is claiming victory. Patarroyo has tested his vaccine on hundreds of soldiers stationed in Colombia's Amazon lowlands, where malaria is endemic.
October 11, 2009 |
Several large health maintenance organizations and insurers in California have agreed to refrain from charging co-payments or deductibles for vaccinating patients against the H1N1 flu. State regulators said they obtained agreements from the companies to waive all charges for administering the vaccine, which is provided free by the federal government. "The likelihood that some health insurers would charge some administrative fee for the vaccine was very, very high," state Insurance Commissioner Steve Poizner said in a conference call.
October 20, 2009 |
A secondary analysis of data from the Thai AIDS vaccine trial -- announced last month to much acclaim -- suggests that the vaccine might provide some protection against the virus, but that the results are not statistically significant. In short, they could have come about merely by chance. Initial results from the trial involving more than 16,000 people had shown that the vaccine reduced infections by about 31% and that the results, though limited, were statistically significant. But the new analysis, which was part of the trial protocol, showed that it seemed to reduce infections by 26%. Results from the secondary analysis have been circulating for a couple of weeks, but the full results of the trial did not become available until they were published online in the New England Journal of Medicine and announced today at a conference in Paris.